COMPLETED

Engaging Native Hawaiian/Pacific Islanders and Activating Communities to Take Steps (ENACTS)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Our Specific Aims are: 1. At the individual level, to compare within-person change in BP and secondary outcomes between the intervention and control groups. 2. At the family level, to evaluate ENACTS' effects on BP and secondary outcomes as within-person change in family members who provide primary support, and as mean change in other adult family members who are not directly engaged in the intervention. 3. At the policy level, to evaluate the intervention's ability to influence grocery store policy on clearly identifying foods that are low in sodium or high in potassium, some of which might not be easily identified with existing labels (e.g., fresh produce). ENACTS combines empirically supported elements of existing programs, thus increasing its probability of success. It aligns with the American Heart Association's call for multilevel prevention.

Official Title

Engaging Native Hawaiian/Pacific Islanders and Activating Communities to Take Steps (ENACTS)

Quick Facts

Study Start:2018-06-15
Study Completion:2025-01-24
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT03484364

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-reported physician diagnosis of hypertension and/or type 2 diabetes confirmed by a prescription for an anti-hypertensive medication and/or type 2 diabetes medication;
  2. * Self-reported NHPI race;
  3. * \*Age 18 years and older at enrollment;
  4. * Measured systolic BP ≥ 140 mmHg on enrollment; measured baseline fasting glucose \>125
  5. * reliable internet access
  6. * computer or Smartphone
  7. * current email address
  8. * \*Ability to understand written and spoken English; and
  9. * \*Ability and willingness to follow all study protocols.
  1. * Pregnant or planning on becoming pregnant throughout the course of the study;
  2. * Currently undergoing dialysis or treatment for a terminal illness;

Contacts and Locations

Principal Investigator

denise dillard
PRINCIPAL_INVESTIGATOR
Washington State University

Study Locations (Sites)

National Recruitment via Facebook and Internet
Seattle, Washington, 98101
United States

Collaborators and Investigators

Sponsor: Washington State University

  • denise dillard, PRINCIPAL_INVESTIGATOR, Washington State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-06-15
Study Completion Date2025-01-24

Study Record Updates

Study Start Date2018-06-15
Study Completion Date2025-01-24

Terms related to this study

Additional Relevant MeSH Terms

  • Hypertension